rs1408113895
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_024312.5(GNPTAB):c.99delC(p.Ala34ProfsTer49) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. S33S) has been classified as Likely benign.
Frequency
Consequence
NM_024312.5 frameshift
Scores
Clinical Significance
Conservation
Publications
- GNPTAB-mucolipidosisInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- mucolipidosisInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
- mucolipidosis type IIInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia, Genomics England PanelApp
- mucolipidosis type III, alpha/betaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, G2P, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GNPTAB | ENST00000299314.12 | c.99delC | p.Ala34ProfsTer49 | frameshift_variant | Exon 1 of 21 | 1 | NM_024312.5 | ENSP00000299314.7 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Pseudo-Hurler polydystrophy Pathogenic:1
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
Pseudo-Hurler polydystrophy;C2673377:Mucolipidosis type II Pathogenic:1
This sequence change creates a premature translational stop signal (p.Ala34Profs*49) in the GNPTAB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GNPTAB are known to be pathogenic (PMID: 19617216, 25107912). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with Mucolipidosis type II (PMID: 27662472, 29872134). ClinVar contains an entry for this variant (Variation ID: 496456). For these reasons, this variant has been classified as Pathogenic. -
Mucolipidosis type II Pathogenic:1
Variant summary: This c.99delC variant causes a frameshift, which alters the proteins amino acid sequence beginning at position 34 and leads to a premature termination codon 48 amino acid downstream. It is predicted to cause a truncated or absent protein product. Mutation taster predicts this variant to be disease-causing. The variant was not observed in the large and broad cohorts of the ExAC project or ESP. The variant of interest has not, to our knowledge, been reported in affected individuals via publications, clinical laboratories, or databases; nor evaluated for functional impact by in vivo/vitro studies. Truncations downstream of this position have been listed as disease variants by HGMD and ClinVar (e.g. Gln104Term, Gln278Term, etc). Considering all, this variant has been classified as Likely Pathogenic until additional information becomes available. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at